Commissioner Hadja Lahbib addressed the European Parliament on December 12, 2024, focusing on the critical theme of gender in health. Her speech articulates a vision aimed at making women's health needs more visible and central to health policies across the European Union. Lahbib’s core proposal stresses the necessity of integrating gender sensitivity into health data collection, research, and policy frameworks.
Concrete Proposals and Policy Directions Lahbib highlighted three primary areas: improving data collection with a gender lens, embedding gender mainstreaming throughout health policies, and reinforcing sexual and reproductive health rights. She emphasized that biological and socio-economic differences between men and women impact disease prevalence and treatment efficacy, advocating for the inclusion of women in clinical research and product testing. Concrete examples include promoting projects like the Gender Differences in Coronary Artery Disease (GENCAD) and adhering to directives combating violence against women, underscoring an approach that targets tailored healthcare strategies rather than one-size-fits-all solutions.
Policy Cleavages and Institutional Impact Her remarks reflect a push towards increasing EU powers in coordinating gender-sensitive health policies, balancing the delicate division of competence where healthcare remains primarily a Member State responsibility. This implies strengthening EU-level collaboration and data sharing but without overriding national sovereignty. The speech also calls for greater inclusion of women in developing industry safety standards, moving against historic male-centric norms in product safety testing.
Stakeholder Impacts The proposed shift positively affects EU consumers and women's health advocates by promoting healthcare equity and tailored treatments. Health professionals, predominantly women, might experience strengthened recognition and support. However, the pharmaceutical and medical research sectors could face increased regulatory and operational demands to include gender dimensions rigorously, potentially raising compliance costs and research complexity. National authorities would need to enhance cooperation and data harmonization, aligning with EU priorities without losing autonomy.
In summary, Lahbib’s address advocates for a more nuanced, gender-aware health ecosystem in the EU. It calls for concrete political action on data, policy mainstreaming, and reproductive rights, signaling a notable step towards integrating gender considerations firmly into the European health agenda.
← Atlas › News › Health & Lifestyle